Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 267614, 12 pages
http://dx.doi.org/10.1093/ecam/nep188
Original Article

Water Extract of Ashwagandha Leaves Limits Proliferation and Migration, and Induces Differentiation in Glioma Cells

1Department of Biotechnology, Guru Nanak Dev University, Amritsar 143005, India
2National Institute of Advanced Industrial Science & Technology (AIST), Central 4, 1-1-1 Higashi, Tsukuba, Ibaraki 305-8562, Japan

Received 30 June 2009; Accepted 19 October 2009

Copyright © 2011 Hardeep Kataria et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Jayaprakasam, Y. Zhang, N. P. Seeram, and M. G. Nair, “Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves,” Life Sciences, vol. 74, no. 1, pp. 125–132, 2003. View at Publisher · View at Google Scholar
  2. L.-C. Mishra, B. B. Singh, and S. Dagenais, “Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review,” Alternative Medicine Review, vol. 5, no. 4, pp. 334–346, 2000. View at Google Scholar
  3. T. Kuboyama, C. Tohda, J. Zhao, N. Nakamura, M. Hattori, and K. Komatsu, “Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha,” NeuroReport, vol. 13, no. 14, pp. 1715–1720, 2002. View at Google Scholar
  4. N. Widodo, K. Kaur, B. G. Shrestha et al., “Selective killing of cancer cells by leaf extract of ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect,” Clinical Cancer Research, vol. 13, no. 7, pp. 2298–2306, 2007. View at Publisher · View at Google Scholar · View at PubMed
  5. K. Kaur, G. Rani, N. Widodo et al., “Evaluation of the anti-proliferative and anti-oxidative activities of leaf extract from in vivo and in vitro raised Ashwagandha,” Food and Chemical Toxicology, vol. 42, no. 12, pp. 2015–2020, 2004. View at Publisher · View at Google Scholar · View at PubMed
  6. P. Benda, J. Lightbody, G. Sato, L. Levine, and W. Sweet, “Differentiated rat glial cell strain in tissue culture,” Science, vol. 161, no. 3839, pp. 370–371, 1968. View at Google Scholar
  7. C. C. Deocaris, N. Widodo, B. G. Shrestha et al., “Mortalin sensitizes human cancer cells to MKT-077-induced senescence,” Cancer Letters, vol. 252, no. 2, pp. 259–269, 2007. View at Publisher · View at Google Scholar · View at PubMed
  8. J. Parkash and G. Kaur, “Neuronal-glial plasticity in gonadotropin-releasing hormone release in adult female rats: role of the polysialylated form of the neural cell adhesion molecule,” Journal of Endocrinology, vol. 186, no. 2, pp. 397–409, 2005. View at Publisher · View at Google Scholar · View at PubMed
  9. S. Sharma and G. Kaur, “Dietary restriction enhances kainate-induced increase in NCAM while blocking the glial activation in adult rat brain,” Neurochemical Research, vol. 33, no. 7, pp. 1178–1188, 2008. View at Publisher · View at Google Scholar · View at PubMed
  10. L. C. B. Rønn, B. P. Hartz, and E. Bock, “The neural cell adhesion molecule (NCAM) in development and plasticity of the nervous system,” Experimental Gerontology, vol. 33, no. 7-8, pp. 853–864, 1998. View at Publisher · View at Google Scholar
  11. J. B. Harborne, Phytochemical Methods. A Guide to Modern Techniques of Plant Analysis, Chapman and Hall, New York, NY, USA, 3rd edition, 1998.
  12. C. K. Kokate, Pharmacognosy, Nirali Prakasham, Mumbai, India, 16th edition, 2001.
  13. R. Wadhwa, S. C. Kaul, Y. Mitsui, and Y. Sugimoto, “Differential subcellular distribution of mortalin in mortal and immortal mouse and human fibroblasts,” Experimental Cell Research, vol. 207, no. 2, pp. 442–448, 1993. View at Publisher · View at Google Scholar · View at PubMed
  14. U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, vol. 227, no. 5259, pp. 680–685, 1970. View at Publisher · View at Google Scholar
  15. S. Khan, F. Malik, K. A. Suri, and J. Singh, “Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity,” Vaccine, vol. 27, no. 43, pp. 6080–6087, 2009. View at Publisher · View at Google Scholar · View at PubMed
  16. F. Malik, A. Kumar, S. Bhushan et al., “Immune modulation and apoptosis induction: two sides of antitumoural activity of a standardised herbal formulation of Withania somnifera,” European Journal of Cancer, vol. 45, no. 8, pp. 1494–1509, 2009. View at Publisher · View at Google Scholar · View at PubMed
  17. S. K. Bhattacharya, R. K. Goel, R. Kaur, and S. Ghosal, “Antistress activity of sitoindosides VII and VIII, new acylsteryglucosides from Withania somnifera,” Phytotherapy Research, vol. 1, pp. 32–37, 1987. View at Google Scholar
  18. P. U. Devi, A. C. Sharada, F. E. Solomon, and M. S. Kamath, “In vivo growth inhibitory effect of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma 180,” Indian Journal of Experimental Biology, vol. 30, no. 3, pp. 169–172, 1992. View at Google Scholar
  19. N. Widodo, Y. Takagi, B. G. Shrestha, T. Ishii, S. C. Kaul, and R. Wadhwa, “Selective killing of cancer cells by leaf extract of Ashwagandha: components, activity and pathway analyses,” Cancer Letters, vol. 262, no. 1, pp. 37–47, 2008. View at Publisher · View at Google Scholar · View at PubMed
  20. N. Shah, H. Kataria, S. C. Kaul, T. Ishii, G. Kaur, and R. Wadhwa, “Effect of the alcoholic extract of Ashwagandha leaves and its components on proliferation, migration, and differentiation of glioblastoma cells: combinational approach for enhanced differentiation,” Cancer science, vol. 100, no. 9, pp. 1740–1747, 2009. View at Publisher · View at Google Scholar · View at PubMed
  21. M. Toda, M. Miura, H. Asou, I. Sugiyama, T. Kawase, and K. Uyemura, “Suppression of glial tumor growth by expression of glial fibrillary acidic protein,” Neurochemical Research, vol. 24, no. 2, pp. 339–343, 1999. View at Publisher · View at Google Scholar
  22. J. T. Rutka, S. L. Hubbard, K. Fukuyama, K. Matsuzawa, P. B. Dirks, and L. E. Becker, “Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells,” Cancer Research, vol. 54, no. 12, pp. 3267–3272, 1994. View at Google Scholar
  23. P. Cuevas, D. Díaz-González, and M. Dujovny, “Differentiation-inducing activity of neomycin in cultured rat glioma cells,” Neurological Research, vol. 26, no. 4, pp. 401–403, 2004. View at Publisher · View at Google Scholar · View at PubMed
  24. X.-N. Li, Z.-W. Du, Q. Huang, and J.-Q. Wu, “Growth-inhibitory and differentiation-inducing activity of dimethylformamide in cultured human malignant glioma cells,” Neurosurgery, vol. 40, no. 6, pp. 1250–1259, 1997. View at Publisher · View at Google Scholar
  25. J. Wang, X. Wang, S. Jiang et al., “Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells,” Journal of Neuro-Oncology, vol. 82, no. 1, pp. 11–21, 2007. View at Publisher · View at Google Scholar · View at PubMed
  26. J. T. Rutka, S. J. De Armond, J. Giblin, J. R. McCulloch, C. B. Wilson, and M. L. Rosenblum, “Effect of retinoids on the proliferation, morphology and expression of glial fibrillary acidic protein of an anaplastic astrocytoma cell line,” International Journal of Cancer, vol. 42, no. 3, pp. 419–427, 1988. View at Google Scholar
  27. H. Kawamata, M. Tachibana, T. Fujimori, and Y. Imai, “Differentiation-inducing therapy for solid tumors,” Current Pharmaceutical Design, vol. 12, no. 3, pp. 379–385, 2006. View at Publisher · View at Google Scholar
  28. R. Wadhwa, O. M. Pereirak-Smith, R. R. Reddel, Y. Sugimoto, Y. Mitsui, and S. C. Kaul, “Correlation between complementation group for immortality and the cellular distribution of mortalin,” Experimental Cell Research, vol. 216, no. 1, pp. 101–106, 1995. View at Publisher · View at Google Scholar · View at PubMed
  29. E. Michishita, K. Nakabayashi, T. Suzuki et al., “5-Bromodeoxyuridine induces senescence-like phenomena in mammalian cells regardless of cell type or species,” Journal of Biochemistry, vol. 126, no. 6, pp. 1052–1059, 1999. View at Google Scholar
  30. K. Nakabayashi, H. Ogino, E. Michishita, N. Satoh, and D. Ayusawa, “Introduction of chromosome 7 suppresses telomerase with shortening of telomeres in a human mesothelial cell line,” Experimental Cell Research, vol. 252, no. 2, pp. 376–382, 1999. View at Publisher · View at Google Scholar · View at PubMed
  31. S. Takano, R. Wadhwa, Y. Yoshii, T. Nose, S. C. Kaul, and Y. Mitsui, “Elevated levels of mortalin expression in human brain tumors,” Experimental Cell Research, vol. 237, no. 1, pp. 38–45, 1997. View at Publisher · View at Google Scholar · View at PubMed
  32. J. Jin, C. Hulette, Y. Wang et al., “Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease,” Molecular and Cellular Proteomics, vol. 5, no. 7, pp. 1193–1204, 2006. View at Publisher · View at Google Scholar · View at PubMed
  33. M. Shi, J. Jin, Y. Wang et al., “Mortalin: a protein associated with progression of Parkinson disease?” Journal of Neuropathology and Experimental Neurology, vol. 67, no. 2, pp. 117–124, 2008. View at Publisher · View at Google Scholar · View at PubMed
  34. G. M. Edelman and K. L. Crossin, “Cell adhesion molecules: implications for a molecular histology,” Annual Review of Biochemistry, vol. 60, pp. 155–190, 1991. View at Google Scholar
  35. D. F. Figarella-Branger, P. L. Durbec, and G. N. Rougon, “Differential spectrum of expression of neural cell adhesion molecule isoforms and L1 adhesion molecules on human neuroectodermal tumors,” Cancer Research, vol. 50, no. 19, pp. 6364–6370, 1990. View at Google Scholar
  36. M.-C. Gingras, E. Roussel, J. M. Bruner, C. D. Branch, and R. P. Moser, “Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue,” Journal of Neuroimmunology, vol. 57, no. 1-2, pp. 143–153, 1995. View at Publisher · View at Google Scholar
  37. K. Kolkova, N. Pedersen, V. Berezin, and E. Bock, “Identification of an amino acid sequence motif in the cytoplasmic domain of the NCAM-140 kDa isoform essential for its neuritogenic activity,” Journal of Neurochemistry, vol. 75, no. 3, pp. 1274–1282, 2000. View at Google Scholar
  38. A.-K. Perl, U. Dahl, P. Wilgenbus, H. Cremer, H. Semb, and G. Christofori, “Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic β tumor cells,” Nature Medicine, vol. 5, no. 3, pp. 286–291, 1999. View at Publisher · View at Google Scholar · View at PubMed
  39. U. Cavallaro and G. Christofori, “Cell adhesion in tumor invasion and metastasis: Ioss of the glue is not enough,” Biochimica et Biophysica Acta, vol. 1552, no. 1, pp. 39–45, 2001. View at Publisher · View at Google Scholar
  40. K. Edvardsen, N. Brunner, M. Spang-Thomsen, F. S. Walsh, and E. Bock, “Migratory, invasive and metastatic capacity of NCAM transfected rat glioma cells,” International Journal of Developmental Neuroscience, vol. 11, no. 5, pp. 681–690, 1993. View at Publisher · View at Google Scholar
  41. K. Edvardsen, P.-H. Pedersen, R. Bjerkvig et al., “Transfection of glioma cells with the neural-cell adhesion molecule NCAM: effect on glioma-cell invasion and growth in vivo,” International Journal of Cancer, vol. 58, no. 1, pp. 116–122, 1994. View at Publisher · View at Google Scholar
  42. G. C. Owens, E. A. Orr, B. K. Kleinschmidt DeMasters, R. J. Muschel, M. E. Berens, and C. A. Kruse, “Overexpression of a transmembrane isoform of neural cell adhesion molecule alters the invasiveness of rat CNS-1 glioma,” Cancer Research, vol. 58, no. 9, pp. 2020–2028, 1998. View at Google Scholar
  43. S. Prag, E. A. Lepekhin, K. Kolkova et al., “NCAM regulates cell motility,” Journal of Cell Science, vol. 115, no. 2, pp. 283–292, 2002. View at Google Scholar
  44. D. Linnemann, A. Raz, and E. Bock, “Differential expression of cell adhesion molecules in variants of K1735 melanoma cells differing in metastatic capacity,” International Journal of Cancer, vol. 43, no. 4, pp. 709–712, 1989. View at Google Scholar
  45. A.-M. Andersson, N. Moran, H. Gaardsvoll et al., “Characterization of NCAM expression and function in BT4C and BT4Cn glioma cells,” International Journal of Cancer, vol. 47, no. 1, pp. 124–129, 1991. View at Publisher · View at Google Scholar
  46. R. Seidenfaden, A. Krauter, F. Schertzinger, R. Gerardy-Schahn, and H. Hildebrandt, “Polysialic acid directs tumor cell growth by controlling heterophilic neural cell adhesion molecule interactions,” Molecular and Cellular Biology, vol. 23, no. 16, pp. 5908–5918, 2003. View at Publisher · View at Google Scholar